These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2766 related items for PubMed ID: 31115369

  • 21. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.
    Kanda T, Goto T, Hirotsu Y, Masuzaki R, Moriyama M, Omata M.
    Int J Mol Sci; 2020 Feb 23; 21(4):. PubMed ID: 32102237
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Hepatocellular carcinoma and non-alcoholic fatty liver disease.
    Golabi P, Rhea L, Henry L, Younossi ZM.
    Hepatol Int; 2019 Nov 23; 13(6):688-694. PubMed ID: 31701393
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A young patient with type 2 diabetes associated non-alcoholic steatohepatitis, liver cirrhosis, and hepatocellular carcinoma.
    Michel M, Kalliga E, Labenz C, Straub BK, Wörns MA, Galle PR, Schattenberg JM.
    Z Gastroenterol; 2020 Jan 23; 58(1):57-62. PubMed ID: 31931541
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome.
    Michelotti A, de Scordilli M, Palmero L, Guardascione M, Masala M, Roncato R, Foltran L, Ongaro E, Puglisi F.
    Cells; 2021 Aug 09; 10(8):. PubMed ID: 34440803
    [Abstract] [Full Text] [Related]

  • 37. Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease.
    Kanwal F, Kramer JR, Mapakshi S, Natarajan Y, Chayanupatkul M, Richardson PA, Li L, Desiderio R, Thrift AP, Asch SM, Chu J, El-Serag HB.
    Gastroenterology; 2018 Dec 09; 155(6):1828-1837.e2. PubMed ID: 30144434
    [Abstract] [Full Text] [Related]

  • 38. Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis.
    Tovo CV, de Mattos AZ, Coral GP, Sartori GDP, Nogueira LV, Both GT, Villela-Nogueira CA, de Mattos AA.
    World J Gastroenterol; 2023 Jan 14; 29(2):343-356. PubMed ID: 36687125
    [Abstract] [Full Text] [Related]

  • 39. Comparison of clinical and metabolic profiles of lean versus non-lean nonalcoholic fatty liver disease.
    Navarroza AMC, Wong SN.
    Indian J Gastroenterol; 2021 Aug 14; 40(4):380-388. PubMed ID: 34213749
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 139.